<VariationArchive VariationID="2733898" VariationName="NM_000098.3(CPT2):c.1273_1274del (p.Thr425fs)" VariationType="Deletion" Accession="VCV002733898" Version="2" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-06-17" DateCreated="2024-02-14" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2898232" VariationID="2733898">
      <GeneList>
        <Gene Symbol="CPT2" FullName="carnitine palmitoyltransferase 2" GeneID="1376" HGNC_ID="HGNC:2330" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1p32.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="53196824" stop="53214197" display_start="53196824" display_stop="53214197" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="53662100" stop="53679868" display_start="53662100" display_stop="53679868" Strand="+" />
          </Location>
          <OMIM>600650</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000098.3(CPT2):c.1273_1274del (p.Thr425fs)</Name>
      <CanonicalSPDI>NC_000001.11:53210946:AC:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1p32.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="53210947" stop="53210948" display_start="53210947" display_stop="53210948" variantLength="2" positionVCF="53210946" referenceAlleleVCF="GAC" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="53676619" stop="53676620" display_start="53676619" display_stop="53676620" variantLength="2" positionVCF="53676618" referenceAlleleVCF="GAC" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>T425fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.53676619_53676620del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.53676619_53676620del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.53210947_53210948del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.53210947_53210948del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008035.1" sequenceAccession="NG_008035" sequenceVersion="1" change="g.19519_19520del">
            <Expression>NG_008035.1:g.19519_19520del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000098.3" sequenceAccession="NM_000098" sequenceVersion="3" change="c.1273_1274del" MANESelect="true">
            <Expression>NM_000098.3:c.1273_1274del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000089.1" sequenceAccession="NP_000089" sequenceVersion="1" change="p.Thr425fs">
            <Expression>NP_000089.1:p.Thr425fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001330589.2" sequenceAccession="NM_001330589" sequenceVersion="2" change="c.1273_1274del">
            <Expression>NM_001330589.2:c.1273_1274del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001317518.1" sequenceAccession="NP_001317518" sequenceVersion="1" change="p.Thr425fs">
            <Expression>NP_001317518.1:p.Thr425fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000098.3(CPT2):c.1273_1274del (p.Thr425fs) AND Carnitine palmitoyltransferase II deficiency" Accession="RCV003581419" Version="1">
        <ClassifiedConditionList TraitSetID="10067">
          <ClassifiedCondition DB="MedGen" ID="C0342790">Carnitine palmitoyltransferase II deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-11-10" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000098.3(CPT2):c.1273_1274del (p.Thr425fs) AND Encephalopathy, acute, infection-induced, susceptibility to, 4" Accession="RCV004574089" Version="1">
        <ClassifiedConditionList TraitSetID="7602">
          <ClassifiedCondition DB="MedGen" ID="C3280160">Encephalopathy, acute, infection-induced, susceptibility to, 4</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-11-26" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-11-26" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2024-02-14" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16781677</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16996287</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="10067" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6221" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Carnitine palmitoyl transferase 2 deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Carnitine palmitoyltransferase deficiency type 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Carnitine palmitoyltransferase II deficiency</ElementValue>
                <XRef ID="MONDO:0015515" DB="MONDO" />
                <XRef ID="238002005" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CPT2</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Carnitine palmitoyltransferase II (CPT II) deficiency is a disorder of long-chain fatty-acid oxidation. The three clinical presentations are lethal neonatal form, severe infantile hepatocardiomuscular form, and myopathic form (which is usually mild and can manifest from infancy to adulthood). While the former two are severe multisystemic diseases characterized by liver failure with hypoketotic hypoglycemia, cardiomyopathy, seizures, and early death, the latter is characterized by exercise-induced muscle pain and weakness, sometimes associated with myoglobinuria. The myopathic form of CPT II deficiency is the most common disorder of lipid metabolism affecting skeletal muscle and the most frequent cause of hereditary myoglobinuria. Males are more likely to be affected than females.</Attribute>
                <XRef ID="NBK1253" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1121" />
                <XRef ID="1121" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301431</ID>
                <ID Source="BookShelf">NBK1253</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESC, 2014">
                <ID Source="PubMed">25173338</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Carnitine-Palmitoyltransferase-2-Deficiency-ACT-Sheet.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Increased C16 and/or C18:1 Acylcarnitine, Carnitine Palmitoyltransferase II (CPT II) Deficiency and Carnitine Acylcarnitine Translocase (CACT) Deficiency, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C16-C18-Elevated-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, C16 +/- C18:1 Elevated: CPT II or CACT, 2022</CitationText>
              </Citation>
              <XRef ID="157" DB="Orphanet" />
              <XRef ID="C0342790" DB="MedGen" />
              <XRef ID="MONDO:0015515" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="7602" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16567" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Encephalopathy, acute, infection-induced, susceptibility to, 4</ElementValue>
                <XRef ID="MONDO:0013633" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">IIAE4</ElementValue>
                <XRef Type="MIM" ID="614212" DB="OMIM" />
              </Symbol>
              <XRef ID="263524" DB="Orphanet" />
              <XRef ID="C3280160" DB="MedGen" />
              <XRef ID="MONDO:0013633" DB="MONDO" />
              <XRef Type="MIM" ID="614212" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7977456" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="4815764|MedGen:C0342790" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004292321" DateUpdated="2024-02-14" DateCreated="2024-02-14" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16781677</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16996287</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16996287</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Thr425Trpfs*6) in the CPT2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CPT2 are known to be pathogenic (PMID: 16781677, 16996287). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with carnitine palmitoyltransferase II deficiency (PMID: 16996287). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CPT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.53676619_53676620del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0342790" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9817682" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2024-06-17">
        <ClinVarSubmissionID localKey="NM_000098.3:c.1273_1274del|OMIM:614212" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV005058539" DateUpdated="2024-06-17" DateCreated="2024-06-17" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000098.3:c.1273_1274del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="614212" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7977456" TraitType="Disease" MappingType="XRef" MappingValue="C0342790" MappingRef="MedGen">
        <MedGen CUI="C0342790" Name="Carnitine palmitoyltransferase II deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9817682" TraitType="Disease" MappingType="XRef" MappingValue="614212" MappingRef="OMIM">
        <MedGen CUI="C3280160" Name="Encephalopathy, acute, infection-induced, susceptibility to, 4" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

